ClinicalTrials.gg
RecruitingNCT07692646GlycoFast84Updated Jul 9, 2026

The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix

An interventional study of Diet in Fasting, Obesity (BMI>30) and Sex Difference, sponsored by University of Copenhagen. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Fasting with a site in Denmark — 3 open to participants now, 3 under way, none of them phase 3. Fasting · Denmark.

Started
2026
the only one that year
No phase
9 of 10
2 open now
Registered
10th of 10
by date
Lead sponsor
1 of 10
University of Copenhagen

Among the 10 studies in Fasting with a site in Denmark, this one is the only one that started in 2026, is one of 9 with no phase, and was the 10th registered.

Fasting

392 studies on the registry are indexed under Fasting; 63 are open to participants now.

Browse Fasting studies →

Open to participants now

3 of the 10 studies in Fasting with a site in Denmark are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 45 Fasting studies recruiting now, 15 (33%) set no upper age limit and 24 (53%) stop at 75 or younger; 7 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Fasting with a site in Denmark, or all of them as a file.
02

Study summary

The interventional study will recruit four groups (n=10 per group): Young men and women with normal weight (BMI 18-25), and young men and women with obesity (BMI >30). The study will investigate the effect of 84 hours of fasting on peak fat oxidation, mitochondrial coupling and the extracellular matrix.

Read the detailed description

Four groups of young normal weight men (n=10) and women (n=10) and young obese men (n=10) and women (10) are recruited. After verbal and written information is provided signed consent is obtained.

Prior to the first day of the trial, the participants must complete a four-day dietary and exercise record based on the weighing of all food and beverages consumed and tracking all exercise. This is used to asses the participant's habitual diet and activity level. For female participants, an additional form must be completed regarding their menstrual cycle and form of contraception.

On the two trial days (before and after fasting), participants arrive at the laboratory in the morning, and on the first day, the participant will have fasted since the previous evening. Furthermore, participants have been asked to minimize strenous physical activity for 24 hours leading up to testing. Prior to day 1, participants have been instructed to consume a habitual carbohydrate-rich diet for the 48 hours preceding the first test day.

Initially, the participants' body composition is determined by DXA, after which the participants rest for 15 minutes. Subsequently, blood pressure is measured in the supine position whereafter resting energy expenditure is measured by indirect calorimetry. A venous blood sample is taken from the antecubital vein, as well as a biopsy from the m. vastus lateralis and from the subcutaneous abdominal adipose tissue using the Bergström technique applied with suction. After 30 minutes of rest, a graded exercise test on a cycle ergometer is initiated to determine peak fat oxidation and maximal oxygen uptake. After the test is completed and following a minimum of 10 minutes of rest, handgrip strength and knee extension strength are measured. This concludes the test day.

Thereafter, the 84-hour fast is initiated. During the fasting period, the subjects will communicate by telephone each morning with one of the researchers regarding their well-being and any questions they may have. On day 2 subjects will do 1 hour of submaximal exercise. During the fasting subjects will be provided with electrolyte tablets. Following the 84 hours, the subjects return to the laboratory. Here, the same protocol as described above is carried out. This concludes the test day and the experiment.

03

Conditions studied

  • Fasting
  • Obesity (BMI>30)
  • Sex Difference

Browse trials for

Keywords

  • Muscle metabolism
  • Mitochondrial coupling
  • Extracellular matrix composition
  • Peak fat oxidation
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy normal weight men aged [18,40] and [18,25]
  • Healthy normal weight women [18,40] and BMI [18,25]
  • Healthy obese men [18,40] and BMI [30,40]
  • Healthy obese women [18,40] and BMI [30,40]

Exclusion criteria

Exclusion Criteria:

  • Present or former cardiovascular disease and chronical inflammatory disease
  • Consumption of medications and supplements that influence substrate use at rest and/or during exercise
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Young normal weight men

    BMI \[18, 25\] Age \[18, 40\]

    Other: Diet

  • Experimental
    Young normal weight women

    BMI \[18, 25\] Age \[18, 40\]

    Other: Diet

  • Experimental
    Young obese men

    BMI \[30, 40\] Age \[18, 40\]

    Other: Diet

  • Experimental
    Young obese women

    BMI \[30, 40\] Age \[18, 40\]

    Other: Diet

Interventions

  • OtherDiet

    Long-term fasting (84 hours), physiological testing before and after fasting: sampling of blood, abdominal adipose tissue and skeletal muscle for molecular analysis and respiratory measurements at rest.

06

What researchers measure

Primary outcomes

  1. The effect of fasting and obesity on protein glycosylation of the extracellular matrix in adipose tissue

    The composition and protein glycosylation of the extracellular matrix will be measured in abdominal subcutaneous adipose tissue samples in 20 healthy normal weight men and women and 20 healthy obese men and women.

    Time frame: The fasting will last approximately 84 hours.

Secondary outcomes

  1. The effect of fasting and obesity on peak fat oxidation

    40 participants (20 healthy normal weight men and women and 20 healthy obese men and women) will fast for 84 hours. Before and after the fast, peak fat oxidation (mg fat/min) is measured in an incremental bike test using indirect calorimetry.

    Time frame: The fasting will last approximately 84 hours

Other outcomes

  1. The effect of fasting and obesity on adipose tissue lipolytic capacity, muscle ketone oxidative capacity and mitochondrial coupling.

    The lipolytic capacity will be measured in abdominal subcutaneous adipose tissue samples and the capacity for ketone oxidation in vastus lateralis muscle in 20 healthy normal weight men and women and 20 healthy obese men and women.and In addition mitochondrial respiratory capacity will be measured in the muscle and adipose biopsy samples using high-resolution respirometry (Oxygraphs, Oroboros).

    Time frame: The fasting will last approximately 84 hours.

07

Study locations

1 of 1 sites recruiting
  • Department of Biomedical Sciences
    Copenhagen, 2200, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — When the experiments are concluded and the paper(s) are accepted that data will be able upon reasonable request

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: The data will be available after publication and indefinately

Access criteria: Not known at this state

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Aug 2027, 14 months later.

Of 144 non-industry interventional studies with no phase under Fasting, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 40. This study's planned 14 months is below that.

Counting every sponsor, half of 149 studies reached it within 18 months; a quarter within 6 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2026
First posted
Jul 9, 2026
StartEst.
Jun 2026
Primary completionEst.
Aug 2027
CompletionEst.
Dec 2033
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07692646
Responsible party
Jørn Wulff Helge (Professor, University of Copenhagen) — Principal investigator
First posted
Jul 9, 2026
Start date
Jun 2026 (estimated)
Primary completion
Aug 2027 (estimated)
Completion
Dec 2033 (estimated)
Last update
Jul 9, 2026

Study contacts

Jørn W Helge, PhD
Contact
jhelge@sund.ku.dk
+4528757506

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion